75 related articles for article (PubMed ID: 5919966)
1. [The therapeutic nightmare].
Olin GA; Göth E; Liljestrand A; Werkö L
Lakartidningen; 1966 Mar; 63(9):847-57. PubMed ID: 5919966
[No Abstract] [Full Text] [Related]
2. Fact sheet on Therapeutic Nightmare and "the pill".
Hardt RA
West Med Med J West; 1966 Feb; 7(2):21-5. PubMed ID: 5951980
[No Abstract] [Full Text] [Related]
3. Setting the record straight on PDR criticisms.
Mehta M
Postgrad Med; 2000 Jan; 107(1):22. PubMed ID: 10649658
[No Abstract] [Full Text] [Related]
4. Editorial: limitations of the physicians' desk reference 2007.
Mindel JS; Teich SA; Teich CM; Beam P
Surv Ophthalmol; 2008; 53(1):82-4. PubMed ID: 18191659
[No Abstract] [Full Text] [Related]
5. Retrospective view of the interfacial relationship of the pharmaceutical industry with the Food and Drug Administration and the United States Pharmacopeia.
Hammer HF
J Parenter Sci Technol; 1984; 38(4):159-63. PubMed ID: 6491859
[No Abstract] [Full Text] [Related]
6. Knowledge is power: legislative control of drug industry trade secrets.
O'Reilly JT
Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981
[No Abstract] [Full Text] [Related]
7. FDA action spurs change in groups' drug programs.
Perry PA
Hosp Mater Manage; 1989 Nov; 14(11):1, 13-4. PubMed ID: 10295911
[No Abstract] [Full Text] [Related]
8. Another round over generics.
Kosterlitz J
Natl J (Wash); 1985 Oct; 17(42):2373, 2376. PubMed ID: 10274030
[No Abstract] [Full Text] [Related]
9. Therapeutic orphans.
Shirkey H
Pediatrics; 1999 Sep; 104(3 Pt 2):583-4. PubMed ID: 10469793
[No Abstract] [Full Text] [Related]
10. The Prescription Drug User Fee Act: is a faster Food and Drug Administration always a better Food and Drug Administration?
Zelenay JL
Food Drug Law J; 2005; 60(2):261-338. PubMed ID: 16094773
[No Abstract] [Full Text] [Related]
11. Plugs for drugs.
Masson A; Rubin PH
Regulation; 1986; 10(1):37-43, 53. PubMed ID: 10280556
[No Abstract] [Full Text] [Related]
12. The United States Food and Drug Administration and the end of antibiotics.
Shlaes DM; Moellering RC
Clin Infect Dis; 2002 Feb; 34(3):420-2. PubMed ID: 11774094
[No Abstract] [Full Text] [Related]
13. What's in a name? Generic vs brand name drugs.
Levin AA
Health PAC Bull; 1986 Jun; 16(5):37, 39. PubMed ID: 10276741
[No Abstract] [Full Text] [Related]
14. An update on the therapeutic orphan.
Wilson JT
Pediatrics; 1999 Sep; 104(3 Pt 2):585-90. PubMed ID: 10469794
[No Abstract] [Full Text] [Related]
15. Bolar agrees to guilty plea in generic drug probe.
Wagner M
Mod Healthc; 1991 Mar; 21(9):17. PubMed ID: 10109180
[No Abstract] [Full Text] [Related]
16. Initial responses to recommendations of the Blue Ribbon Committee on Generic Medicines.
Heller WM
Am J Hosp Pharm; 1993 Feb; 50(2):318-22. PubMed ID: 8480792
[No Abstract] [Full Text] [Related]
17. Generic drug purchasing.
Mehl B
Hosp Pharm; 1988 Feb; 23(2):162-4 contd. PubMed ID: 10286432
[No Abstract] [Full Text] [Related]
18. Remarks by the Commissioner of Food and Drugs.
Kessler DA
Food Drug Law J; 1995; 50(2):327-34. PubMed ID: 10343001
[No Abstract] [Full Text] [Related]
19. The Food and Drug Administration drug registration and listing system.
Slavin M
Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
[No Abstract] [Full Text] [Related]
20. Personal responsibility and the Food and Drug Law.
Janssen WF
FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122
[No Abstract] [Full Text] [Related]
[Next] [New Search]